Loss of FMRP: Increased synthesis of SLC16A1 (a monocarboxylate transporter) may favor hepatic transport of KB (terminal breakdown product of mitochondrial β oxidation). This may contribute to the elevation of the circulating levels of KB acetone and acetoacetate in FMR1 KO mouse.